122 related articles for article (PubMed ID: 18533260)
21. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
23. Isochromosome (6p) in Waldenstrom's macroglobulinemia.
White AD; Clark RE; Jacobs A
Cancer Genet Cytogenet; 1992 Jan; 58(1):89-91. PubMed ID: 1728957
[TBL] [Abstract][Full Text] [Related]
24. Genetic abnormalities in Waldenström's macroglobulinemia.
Adamia S; Pilarski PM; Belch AR; Pilarski LM
Clin Lymphoma Myeloma; 2009 Mar; 9(1):30-2. PubMed ID: 19362966
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
[TBL] [Abstract][Full Text] [Related]
26. WSU-WM and BCWM.1 should not be assumed to represent Waldenström macroglobulinemia cell lines.
Bergsagel PL; Kuehl WM
Blood; 2008 Aug; 112(3):917. PubMed ID: 18650470
[No Abstract] [Full Text] [Related]
27. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
Ng SB; Khoury JD
Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous Waldenstrom's macroglobulinemia with "deck-chair" sign treated with cyclophosphamide.
Autier J; Buffet M; Pinquier L; Merlat-Guitard AI; Carlotti A; Franck N; Gorin I; Dupin N
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):45-7. PubMed ID: 15692513
[TBL] [Abstract][Full Text] [Related]
29. [Special morphological changes of pathologic cells in two cases of Waldenström's macroglobulinemia].
Chen XL; Li FL; Zhao CL; Jiang DZ; Qin P; Wang YF; Yan SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):220-3. PubMed ID: 15157338
[TBL] [Abstract][Full Text] [Related]
30. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic findings in mouse multiple myeloma and Waldenström's macroglobulinemia.
van den Akker TW; Radl J; Franken-Postma E; Hagemeijer A
Cancer Genet Cytogenet; 1996 Feb; 86(2):156-61. PubMed ID: 8603345
[TBL] [Abstract][Full Text] [Related]
32. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with inv(16)(p13q22) as a sole genetic abnormality.
Frater JL; Mirkhaef M; Batanian JR
Cancer Genet Cytogenet; 2007 Apr; 174(2):161-5. PubMed ID: 17452259
[TBL] [Abstract][Full Text] [Related]
33. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
34. A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia.
Chong YY; Lau LC; Lui WO; Lim P; Lim E; Tan PH; Tan P; Ong YY
Cancer Genet Cytogenet; 1998 May; 103(1):65-7. PubMed ID: 9595048
[TBL] [Abstract][Full Text] [Related]
35. Complex karyotype including 14q+ marker in a case of Waldenström's macroglobulinemia.
Cigudosa JC; Calasanz MJ; Pérez C; Rifón J; Cuesta B; Gullon A
Cancer Genet Cytogenet; 1994 Apr; 73(2):169-70. PubMed ID: 8174094
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal abnormalities in Waldenström's macroglobulinemia.
Carbone P; Caradonna F; Granata G; Marcenò R; Cavallaro AM; Barbata G
Cancer Genet Cytogenet; 1992 Jul; 61(2):147-51. PubMed ID: 1638495
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic aspects of Waldenström's macroglobulinemia.
Anders GJ; Gouw WL
Ned Tijdschr Geneeskd; 1966 Oct; 110(43):1930-2. PubMed ID: 4962663
[No Abstract] [Full Text] [Related]
38. Nonfluent aphasia in a patient with Waldenstrom's macroglobulinemia.
Donix M; Beuthien-Baumann B; von Kummer R; Gahn G; Thomas F; Holthoff V
J Clin Neurosci; 2007 Jun; 14(6):601-3. PubMed ID: 17376690
[TBL] [Abstract][Full Text] [Related]
39. Chromosome changes in 19 patients with Waldenström's macroglobulinemia.
Palka G; Spadano A; Geraci L; Fioritoni G; Dragani A; Calabrese G; Guanciali Franchi P; Stuppia L
Cancer Genet Cytogenet; 1987 Dec; 29(2):261-9. PubMed ID: 3119188
[TBL] [Abstract][Full Text] [Related]
40. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
